PCR Tokyo Valves 2024

17 Feb 2024

TAVI

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

Sponsored by Medtronic

Anchorpersons: S. C. C. Lam, T. Sakamoto

Discussants: S. Shirai, R. Singh Rao, K. C. Y. So, H. Zhang

SHOW MORE

Summary

In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons between TAVR and SAVR, and assess the importance of commissure and coronary alignment, as determined by post-procedure CT, on successful coronary cannulation.

Learning Objectives

To know what each of these data is evaluating
To know what features of the Evolut product would benefit my patients from these data
To know from the data how it differs from the other treatment methods
To know treatment strategies for low-risk patients from lifetime management perspective

Speaker

Long-term durability - Notion ten-year data

Download presentation

Dr. Gilbert Tang

Speaker

Four-year outcome from the Low Risk trial

Download presentation

Yohei Ohno

Speaker

Cannulate TAVR study with the latest self-expandable valve

Download presentation